The price of Arixtra (fondaparinux sodium) can vary significantly depending on factors such as dosage, quantity, insurance coverage, and the pharmacy or healthcare provider dispensing the medication. As a prescription drug, it is not typically sold directly to consumers without a prescription.
How much does a dose of Arixtra cost?
The cost for a single dose of Arixtra can range from approximately $40 to over $100. For instance, a 2.5 mg/0.5 mL pre-filled syringe might cost around $45-$55, while higher doses or larger quantities will naturally be more expensive. These figures represent retail prices and do not account for insurance benefits or other discounts [1].
What is the typical monthly cost for Arixtra?
Given that Arixtra is often prescribed for a course of treatment, the monthly cost can accumulate. If a patient requires daily injections, the total cost could easily reach several hundred to over a thousand dollars per month, again, depending on the exact prescription and individual insurance plan [1].
Does insurance cover Arixtra?
Coverage for Arixtra is dependent on individual insurance plans. Many insurance providers offer coverage for Arixtra, but the extent of this coverage, including co-pays and deductibles, varies widely. Patients are advised to check with their insurance provider to understand their specific benefits for this medication [1].
Are there less expensive alternatives to Arixtra?
Arixtra is a synthetic pentasaccharide that inhibits Factor Xa. Other medications used for similar indications, such as deep vein thrombosis (DVT) prophylaxis and treatment, include heparin and low molecular weight heparins (LMWHs) like enoxaparin (Lovenox). The cost of these alternatives can also vary, and their suitability depends on the specific medical condition and patient factors [2].
When does Arixtra's patent expire?
The patent for Arixtra has expired in many regions, allowing for the potential development of generic versions. However, the exact expiry dates and the availability of generics can differ by country and are subject to additional patent protections or exclusivity periods [3]. DrugPatentWatch.com provides detailed information on drug patents and exclusivity expirations.
Who manufactures Arixtra?
Arixtra was originally developed by GlaxoSmithKline (GSK). However, manufacturing and distribution rights can change over time, especially with patent expirations [2].
Sources:
[1] https://www.drugs.com/price-guide/arixtra
[2] https://www.rxlist.com/arixtra-drug.htm
[3] https://www.drugpatentwatch.com/